Search Results - "Aimová, D"
-
1
Oxidation pattern of the anticancer drug ellipticine by hepatic microsomes - similarity between human and rat systems
Published in General physiology and biophysics (01-09-2006)“…Ellipticine is an antineoplastic agent, whose mode of action is based mainly on DNA intercalation, inhibition of topoisomerase II and formation of DNA adducts…”
Get full text
Journal Article -
2
Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 reductase null mice
Published in Carcinogenesis (New York) (01-03-2008)“…Many studies using mammalian cellular and subcellular systems have demonstrated that polycyclic aromatic hydrocarbons, including benzo[a]pyrene (BaP), are…”
Get full text
Journal Article -
3
The Anticancer Drug Ellipticine Forms Covalent DNA Adducts, Mediated by Human Cytochromes P450, through Metabolism to 13-Hydroxyellipticine and Ellipticine N 2-Oxide
Published in Cancer research (Chicago, Ill.) (15-11-2004)“…Abstract Ellipticine is an antineoplastic agent, the mode of action of which is considered to be based on DNA intercalation and inhibition of topoisomerase II…”
Get full text
Journal Article -
4
Formation and persistence of DNA adducts of anticancer drug ellipticine in rats
Published in Toxicology (Amsterdam) (01-07-2007)“…Abstract Ellipticine is an antineoplastic agent, whose mode of antitumor and/or toxic side effects is based on DNA intercalation, inhibition of topoisomerase…”
Get full text
Journal Article -
5
Cytochromes P450 reconstituted with NADPH: P450 reductase mimic the activating and detoxicating metabolism of the anticancer drug ellipticine in microsomes
Published in Neuro-endocrinology letters (01-12-2006)“…Ellipticine is a potent antineoplastic agent exhibiting multiple action mechanisms. Recently, we found that after cytochrome P450 (CYP)-mediated oxidation…”
Get more information
Journal Article -
6
DNA adduct formation by the anticancer drug ellipticine in rats determined by super(32)P postlabeling
Published in International journal of cancer (01-01-2003)“…Ellipticine is a potent antineoplastic agent whose mode of action is considered to be based mainly on DNA intercalation and/or inhibition of topoisomerase II…”
Get full text
Journal Article